• 
  Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, et al.. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. Journal of Hematology and Oncology, 2024, 17 (1), pp.86. ⟨10.1186/s13045-024-01606-w⟩. ⟨hal-04719788⟩
• 
  Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, et al.. Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients. Journal of Hematology and Oncology, 2024, 17 (1), pp.86. ⟨10.1186/s13045-024-01606-w⟩. ⟨hal-04719756⟩
• 
  Ugo Szachnowski, Oliver Sallou, Matéo Boudet, Anthony Bretaudeau, Maxime Wéry, et al.. The 5-Fluorouracil RNA Expression Viewer (5-FUR) Facilitates Interpreting the Effects of Drug Treatment and RRP6 Deletion on the Transcriptional Landscape in Yeast. Yeast, 2024, Online ahead of print. ⟨10.1002/yea.3982⟩. ⟨hal-04718291⟩
• 
  Boris Bardot, Franck Toledo. Targeting MDM4 Splicing in Cancers. Genes, 2017, 8 (2), pp.82. ⟨10.3390/genes8020082⟩. ⟨hal-04717205⟩
• 
  Lia M Pinto, Alexandros Pailas, Max Bondarchenko, Abhishek Bharadwaj Sharma, Katrin Neumann, et al.. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. Nucleic Acids Research, 2024, 52, pp.1136 - 1155. ⟨10.1093/nar/gkad1141⟩. ⟨hal-04716990⟩
• 
  Marcela Carausu, Matthieu Carton, Luc Cabel, Anne Patsouris, Christelle Levy, et al.. Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database. Therapeutic Advances in Medical Oncology, 2022, 14, pp.175883592210770. ⟨10.1177/17588359221077082⟩. ⟨hal-03867853⟩
• 
  Hugo Garcia, Alice Serafin, Flora Silbermann, Esther Porée, Amandine Viau, et al.. Agonists of prostaglandin E 2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies. Proceedings of the National Academy of Sciences of the United States of America, 2022, 119 (18), pp.e2115960119. ⟨10.1073/pnas.2115960119⟩. ⟨hal-03930843⟩
• 
  Octave Joliot. GPI anchored proteins identify gel-like lipid domains in the membrane of the Endoplasmic Reticulum. Cellular Biology. Université Paris sciences et lettres, 2024. English. ⟨NNT : 2024UPSLS013⟩. ⟨tel-04714623⟩
• 
  Emilia Benassai, Ana C Hortelao, Elif Aygun, Asli Alpman, Claire Wilhelm, et al.. High-throughput large scale microfluidic assembly of iron oxide nanoflowers@PS- b -PAA polymeric micelles as multimodal nanoplatforms for photothermia and magnetic imaging. Nanoscale Advances, 2023, 6 (1), pp.126-135. ⟨10.1039/D3NA00700F⟩. ⟨hal-04711159⟩
• 
  Rayan Bensenane, Arnaud Beddok, Fabienne Lesueur, Alain Fourquet, Mathilde Warcoin, et al.. Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia–Telangiectasia Mutated Variant Carriers. Cancers, 2024, 16 (7), pp.1417. ⟨10.3390/cancers16071417⟩. ⟨hal-04535641⟩
• 
  Boutaîna Chandouri, Thomas Naves, May Yassine, Léa Ikhlef, Jérémy Tricard, et al.. Comparison of methods for cancer stem cell detection in prognosis of early stages NSCLC. British Journal of Cancer, 2024, ⟨10.1038/s41416-024-02839-9⟩. ⟨hal-04710240⟩
• 
  Nicolas Jouvin, Pierre Latouche, Charles Bouveyron, Guillaume Bataillon, Alain Livartowski. Greedy clustering of count data through a mixture of multinomial PCA. Computational Statistics, 2020, ⟨10.1007/s00180-020-01008-9⟩. ⟨hal-02278224⟩
• 
  Antoine Vasseur, Luc Cabel, Caroline Hego, Wissam Takka, Olfa Trabelsi Grati, et al.. Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene, 2024, 43 (16), pp.1214-1222. ⟨10.1038/s41388-024-02986-6⟩. ⟨hal-04684301⟩
• 
  Nicolas Captier. Multimodal analysis of radiological, pathological, and transcriptomic data for the prediction of immunotherapy outcome in Non-Small Cell Lung Cancer patients. Cancer. Université Paris sciences et lettres, 2024. English. ⟨NNT : 2024UPSLS012⟩. ⟨tel-04708324⟩
• 
  Panagiotis Papoutsoglou, Raphaël Pineau, Raffaele Leroux, Corentin Louis, Anais l'Haridon, et al.. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma. EMBO Reports, 2024, 25 (3), pp.1022-1054. ⟨10.1038/s44319-024-00075-z⟩. ⟨hal-04615801⟩
• 
  Vincent Hautefeuille, Nicolas Williet, Anthony Turpin, Bertrand Napoleon, Aurélien Dupré, et al.. Ampullary tumors: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, ACHBT, AFC, SFRO, RENAPE, SNFCP, AFEF, SFP, SFR). Digestive and Liver Disease, 2024, 56 (9), pp.1452-1460. ⟨10.1016/j.dld.2024.04.027⟩. ⟨hal-04603000⟩
• 
  Martin Reck, Ernest Nadal, Nicolas Girard, Andrea R. Filippi, Linda W. Martin, et al.. MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB-IIIB NSCLC. Clinical Lung Cancer, 2024, 25 (6), pp.587-593.e3. ⟨10.1016/j.cllc.2024.06.007⟩. ⟨hal-04684299⟩
• 
  Emile Gasser, Emilie Su, Kotryna Vaidžiulytė, Nassiba Abbade, Hamizah Cognart, et al.. Deformation under flow and morphological recovery of cancer cells. Lab on a Chip, 2024, 24 (16), pp.3930-3944. ⟨10.1039/D4LC00246F⟩. ⟨hal-04707405⟩
• 
  Zakhia El Beaino, Laëtitia Fuhrmann, Charlotte Martinat, Anne Vincent-Salomon, Célia Dupain, et al.. Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors. Journal of Pathology, 2024, ⟨10.1002/path.6334⟩. ⟨hal-04687380⟩
• 
  Paul Bastard, Nathalie Cozic, Régis Brion, Nathalie Gaspar, Sophie Piperno-Neumann, et al.. Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience. Pediatric Blood and Cancer, 2024, 71 (7), pp.e31029. ⟨10.1002/pbc.31029⟩. ⟨inserm-04707228⟩

4 119

3 721